Trial site
Kurume University Hospital
- 28running trials
- 19closed trials
The trials here
What the 47 trials at this site are about, from their registry records.
- Conditions
- Lung cancer19 trials
- Ulcerative colitis8 trials
- Crohn's disease4 trials
- Narcolepsy3 trials
- Spinal muscular atrophy3 trials
- Acute lymphoblastic leukaemia2 trials
- Amyloidosis2 trials
- Alopecia areata1 trial
- Diabetic eye disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- and 5 more
- Phase
- Phase 331 trials
- Phase 27 trials
- Phase 1/23 trials
- Phase 2/32 trials
- Phase 11 trial
- Status
- Completed19 trials
- Active, not recruiting15 trials
- Recruiting10 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Amgen10 trials
- Takeda9 trials
- EMD Serono Research & Development Institute, Inc.6 trials
- Daiichi Sankyo3 trials
- Abivax S.A.2 trials
- and 14 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Active, not recruiting
Active, not recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Active, not recruiting
Active, not recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Active, not recruiting
Active, not recruiting
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Crohn's disease3 recruiting
- Ulcerative colitis3 recruiting
- Amyloidosis1 recruiting
- Diabetic eye disease1 recruiting
- Endometrial cancer1 recruiting
- Narcolepsy1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Completed
Completed
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
Completed
Completed
Completed
Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
Completed
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Completed
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026